Your institution may have access to this item. Find your institution then sign in to continue.
Title
Immune privilege or inflammation? Insights into the Fas ligand enigma.
Authors
O'Connell, J; Houston, A; Bennett, M W; O'Sullivan, G C; Shanahan, F
Abstract
Fas ligand (FasL) has become an enigmatic molecule: some evidence indicates that it contributes to immune privilege in tissues and tumors, whereas other data demonstrates that FasL can elicit inflammation. New findings may begin to reconcile the paradoxical effects of FasL.